Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for AxoGen, Inc. (AXGN : NSDQ)

• Company Description    AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States. Number of Employees: 451

• Price / Volume Information    Yesterday's Closing Price: $9.40 Daily Weekly Monthly 20 Day Moving Average: 467,681 shares Shares Outstanding: 41.98 (millions) Market Capitalization: $394.62 (millions) Beta: 0.75 52 Week High: $22.82 52 Week Low: $6.87 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 29.66% 41.53% 12 Week 27.20% 37.47% Year To Date 0.32% 18.83%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 13631 PROGRESS BLVD. SUITE 400 - ALACHUA,FL 32615 USA ph: 386-462-6800 fax: 386-462-6801 investorrelations@axogeninc.com http://www.axogeninc.com

• General Corporate Information    Officers Karen Zaderej - Chief Executive Officer; President and Chairman of Peter J. Mariani - Executive Vice President and Chief Financial Offic Quentin S. Blackford - Director Gregory G. Freitag - Director Mark Gold - Director Peer Information AxoGen, Inc. (ABMD) AxoGen, Inc. (DMDS) AxoGen, Inc. (CPWY.) AxoGen, Inc. (EQUR) AxoGen, Inc. (ECIA) AxoGen, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 05463X106 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/03/22 Share - Related Items Shares Outstanding: 41.98 Most Recent Split Date: 7.00 (1.05:1) Beta: 0.75 Market Capitalization: $394.62 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.17 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.67 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/03/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.47 Price/Cash Flow: - Price / Sales: 3.10 EPS Growth vs. Year Ago Period: -73.33% vs. Previous Quarter: -116.67% Sales Growth vs. Year Ago Period: -0.10% vs. Previous Quarter: -1.68% ROE 03/31/22 - -25.97 12/31/21 - -21.12 09/30/21 - -21.68 ROA 03/31/22 - -14.32 12/31/21 - -11.92 09/30/21 - -12.62 Current Ratio 03/31/22 - - 12/31/21 - 5.23 09/30/21 - 5.78 Quick Ratio 03/31/22 - - 12/31/21 - 4.54 09/30/21 - 5.12 Operating Margin 03/31/22 - -23.56 12/31/21 - -19.33 09/30/21 - -20.14 Net Margin 03/31/22 - -24.98 12/31/21 - -21.19 09/30/21 - -21.59 Pre-Tax Margin 03/31/22 - - 12/31/21 - -21.19 09/30/21 - -21.59 Book Value 03/31/22 - - 12/31/21 - 2.71 09/30/21 - 2.77 Inventory Turnover 03/31/22 - - 12/31/21 - 1.56 09/30/21 - 1.68 Debt-to-Equity 03/31/22 - - 12/31/21 - 0.58 09/30/21 - 0.59 Debt-to-Capital 03/31/22 - - 12/31/21 - 36.83 09/30/21 - 36.93

Powered by Zacks Investment Research ©